{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:03:56Z","timestamp":1791633836188,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003760","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003760","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa Operacional Regional do Norte"},{"name":"Quadro de Refer\u00eancia Estrat\u00e9gico Nacional (QREN)"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vaccine.2014.11.013","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T18:35:15Z","timestamp":1416508515000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells"],"prefix":"10.1016","volume":"33","author":[{"given":"Andrea","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eg\u00eddio","family":"Torrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra G.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcio","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Appelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Correia-Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio G.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.11.013_bib0250","series-title":"Global tuberculosis control","author":"WHO","year":"2011"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0010","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","article-title":"Future vaccination strategies against tuberculosis: thinking outside the box","volume":"33","author":"Kaufmann","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccm.2009.08.014","article-title":"New vaccines against tuberculosis","volume":"30","author":"Lambert","year":"2009","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.micpath.2012.12.002","article-title":"Vaccination against tuberculosis: how can we better BCG","volume":"58","author":"Pitt","year":"2013","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0050","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/eji.201142158","article-title":"Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection","volume":"42","author":"Pearl","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.it.2010.12.001","article-title":"Cellular response to mycobacteria: balancing protection and pathology","volume":"32","author":"Torrado","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0060","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.1200061","article-title":"IFN-gamma from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection","volume":"190","author":"Green","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tube.2007.07.001","article-title":"Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis","volume":"87","author":"Goldsack","year":"2007","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0075","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/IAI.00685-08","article-title":"Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis","volume":"77","author":"Tchilian","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2567.2001.01305.x","article-title":"Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation","volume":"104","author":"Leal","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0085","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstrom","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0090","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.4049\/jimmunol.0900947","article-title":"Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis","volume":"183","author":"Aagaard","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"Scriba","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0100","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cytogfr.2010.10.004","article-title":"IL-17 and Th17 cells in tuberculosis","volume":"21","author":"Torrado","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0110","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG DeltaureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","volume":"204","author":"Desel","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.138.1.293","article-title":"The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis","volume":"138","author":"Orme","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0120","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.4049\/jimmunol.140.10.3589","article-title":"Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection","volume":"140","author":"Orme","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0125","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.20100265","article-title":"Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis","volume":"207","author":"Cruz","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0130","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.177.3.1416","article-title":"Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4T cells during mycobacterial infection","volume":"177","author":"Cruz","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/intimm\/dxq459","article-title":"TLR2 deficiency by compromising p19 (IL-23) expression limits Th17 cell responses to Mycobacterium tuberculosis","volume":"23","author":"Teixeira-Coelho","year":"2011","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/IAI.00820-10","article-title":"Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression","volume":"79","author":"Fraga","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0145","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0150","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.180.12.7948","article-title":"Regulation of IL-17 in human CCR6+ effector memory T cells","volume":"180","author":"Liu","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0155","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0160","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jaci.2013.03.015","article-title":"Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease","volume":"131","author":"Hirahara","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0165","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0170","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0175","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0180","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20052433","article-title":"Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates","volume":"203","author":"Wille-Reece","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0185","doi-asserted-by":"crossref","first-page":"e100830","DOI":"10.1371\/journal.pone.0100830","article-title":"To achieve an earlier IFN-gamma response is not sufficient to control Mycobacterium tuberculosis infection in mice","volume":"9","author":"Vilaplana","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0190","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4T cell mediated control of M. tuberculosis infection in vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0195","doi-asserted-by":"crossref","first-page":"e1002196","DOI":"10.1371\/journal.ppat.1002196","article-title":"What do we really know about how CD4T cells control Mycobacterium tuberculosis?","volume":"7","author":"Torrado","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0200","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/nm1221","article-title":"Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis","volume":"11","author":"Kaufmann","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri2960","article-title":"Immunological biomarkers of tuberculosis","volume":"11","author":"Walzl","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0210","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells","volume":"190","author":"Lindenstrom","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0215","doi-asserted-by":"crossref","first-page":"104ra0","DOI":"10.1126\/scitranslmed.3002949","article-title":"Human TH17 cells are long-lived effector memory cells","volume":"3","author":"Kryczek","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0220","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mi.2012.135","article-title":"Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis","volume":"6","author":"Gopal","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0225","first-page":"712","article-title":"CXCR5(+) T helper cells mediate protective immunity against tuberculosis","volume":"123","author":"Slight","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.it.2011.10.003","article-title":"Neutrophils in tuberculosis: friend or foe","volume":"33","author":"Lowe","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chom.2012.07.009","article-title":"Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages","volume":"12","author":"Yang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0240","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2014.11.013_bib0245","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:21:19Z","timestamp":1759400479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14015370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0264410X14015370"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}